Answers are grounded in this paper and cite their sources.
fusion gene and highlight the potential of CRISPR-based strategies for targeting cancer at its genetic level. This approach also holds promise for the development of highly specific and effective therapies for many other oncogenic fusion driven cancers.
No takes yet. Share an insight, caveat, or question.
Carle et al. (2025) studied this question.